1-Bromopropane (1-BP); Draft Toxic Substances Control Act (TSCA) Risk Evaluation and TSCA Science Advisory Committee on Chemicals (SACC) Meetings; Notice of Availability and Public Meetings, 39830-39833 [2019-17222]

Download as PDF 39830 Federal Register / Vol. 84, No. 155 / Monday, August 12, 2019 / Notices EPA case No. Chemical identity P–19–0072 ........................... 1-Butanol, reaction products with 2-[(2-propen-1yloxy)methyl]oxirane. P–18–0170 ........................... 1-Propanaminium, N,N′-(oxydi-2,1-ethanediyl)bis[3chloro-2-hydroxy-N,N-dimethyl-, chloride (1:2) (CASRN: 96320–92–2). 1H-Imidazole, 1,2,4,5-tetramethyl- (CASRN: 1739-83-9) P–18–0011 ........................... P–18–0239, P–18–0240 ...... (P–18–0239) N-alkyl propanamide, (P–18–0240) Nalkyl acetamide (generic names). J–19–0019, J–19–0020 ....... Genetically modified microorganism for the production of an enzyme substance (generic name). P–19–0065 ........................... 2lambda5, 4lambda5, 6lambda5- 1,3,5,2,4,6 Triazatriphosphorine, 2,2,4,4,6,6—hexaphenoxy(CASRN: 1184–10–7). Benzenedicarboxylic acid, reaction products with isobenzofurandione and diethylene glycol (generic name). Alkylmultiheteroatom,2-functionalisedalkyl-2hydroxyalkyl-, polymer with alkylheteroatommultialkylfunctionalised carbomonocyleheteroatom and multiglycidylether difunctionalised polyalkylene glycol (generic name). Fatty acids, polymers with alkanoic acid and substituted carbomonocycle, peroxide-initiated, polymers with alkanoic acid esters and substituted carbomonocycle, ammonium salts; polymer exemption flag (generic name). Oxoalkylcarboxylic acid, sodium salt (generic name) ..... P–19–0012 ........................... P–18–0404 ........................... P–18–0260 ........................... P–18–0125 ........................... Authority: 15 U.S.C. 2601 et seq. Dated: July 29, 2019. Leo Schweer, Chief, New Chemicals Management Branch, Chemical Control Division, Office of Pollution Prevention and Toxics. [FR Doc. 2019–17151 Filed 8–9–19; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–OPPT–2019–0235; FRL–9997–25] 1-Bromopropane (1–BP); Draft Toxic Substances Control Act (TSCA) Risk Evaluation and TSCA Science Advisory Committee on Chemicals (SACC) Meetings; Notice of Availability and Public Meetings Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: jspears on DSK3GMQ082PROD with NOTICES Website link EPA is announcing the availability of documents and dates for the peer review of the draft risk evaluation for 1-Bromopropane (1–BP). The purpose of the risk evaluations under the Toxic Substances Control Act (TSCA) is to determine whether a chemical substance presents an SUMMARY: VerDate Sep<11>2014 17:16 Aug 09, 2019 Jkt 247001 https://www.epa.gov/reviewing-new-chemicals-undertoxic-substances-control-act-tsca/tsca-section-5a3cdetermination-245. https://www.epa.gov/reviewing-new-chemicals-undertoxic-substances-control-act-tsca/tsca-section-5a3cdetermination-244. https://www.epa.gov/reviewing-new-chemicals-undertoxic-substances-control-act-tsca/tsca-section-5a3cdetermination-243. https://www.epa.gov/reviewing-new-chemicals-undertoxic-substances-control-act-tsca/tsca-section-5a3cdetermination-242. https://www.epa.gov/reviewing-new-chemicals-undertoxic-substances-control-act-tsca/tsca-section-5a3cdetermination-241. https://www.epa.gov/reviewing-new-chemicals-undertoxic-substances-control-act-tsca/tsca-section-5a3cdetermination-240. https://www.epa.gov/reviewing-new-chemicals-undertoxic-substances-control-act-tsca/tsca-section-5a3cdetermination-239. https://www.epa.gov/reviewing-new-chemicals-undertoxic-substances-control-act-tsca/tsca-section-5a3cdetermination-238. https://www.epa.gov/reviewing-new-chemicals-undertoxic-substances-control-act-tsca/tsca-section-5a3cdetermination-237. https://www.epa.gov/reviewing-new-chemicals-undertoxic-substances-control-act-tsca/tsca-section-5a3cdetermination-236 unreasonable risk of injury to health or the environment under the conditions of use, including an unreasonable risk to a relevant potentially exposed or susceptible subpopulation. EPA is also submitting these same documents to the TSCA Science Advisory Committee on Chemicals (SACC) for peer review and is announcing that there will be a 3-day in-person meeting of the TSCA SACC to consider and review these draft risk evaluations. Preceding the in-person meeting, there will be a 3-hour preparatory virtual meeting for the panel to consider the scope and clarity of the draft charge questions for the peer reviews. DATES: Comments: Comments on the draft risk evaluation must be received on or before October 11, 2019. Please submit comments on the draft risk evaluation by August 30, 2019 to allow the SACC time to review and consider them before the peer review meeting. Comments received after August 30, 2019 will still be provided to the SACC for their consideration. For additional instructions, see Unit II.A. and Unit II.B. of the SUPPLEMENTARY INFORMATION. Meetings: The preparatory virtual meeting will be held on August 21, 2019, from 1 p.m. to approximately 4 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 p.m. (EDT). The 3-day in-person meeting will be held on September 10– 12, 2019 from 9:00 a.m. to approximately 5:30 p.m. (EDT). Virtual Meeting: The preparatory virtual meeting will be conducted via webcast and telephone. Registration is open to the public and is required to participate during the preparatory virtual meeting. Please visit https://www.epa.gov/tsca-peer-review website for additional information including how to register. In-Person Meeting: The location of the in-person meeting will be announced on the TSCA SACC website at https:// www.epa.gov/TSCA-Peer-Review. The in-person meeting may also be webcast. Please refer to the TSCA SACC website at https://www.epa.gov/tsca-peer-review for information on how to access the webcast. Please note that for the inperson meeting, the webcast is a supplementary public process provided only for convenience. If difficulties arise resulting in webcasting outages, the inperson meeting will continue as planned. Comments. Submit your comments, identified by docket identification (ID) number EPA–HQ–OPPT–2019–0235, by one of the following methods: ADDRESSES: E:\FR\FM\12AUN1.SGM 12AUN1 Federal Register / Vol. 84, No. 155 / Monday, August 12, 2019 / Notices • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. • Mail: OPPT Docket, Environmental Protection Agency Docket Center (EPA/ DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001. • Hand Delivery: To make special arrangements for hand delivery or delivery of boxed information, please follow the instructions at https:// www.epa.gov/dockets/contacts.html. Additional instructions on commenting or visiting the docket, along with more information about dockets generally, is available at https:// www.epa.gov/dockets. Requests to present oral comments and requests for special accommodations. Submit requests for special accommodations, or requests to present oral comments (in-person or over the telephone) during the webcast and/or the public portion of the peer review meeting to the Designated Federal Official (DFO) listed under FOR FURTHER INFORMATION CONTACT by the deadline identified in the DATES section. Comments received after the date set in the DATES section and prior to the end of the oral public comment period during the meeting for each chemical will still be provided to the SACC for their consideration. jspears on DSK3GMQ082PROD with NOTICES FOR FURTHER INFORMATION CONTACT: TSCA SACC meetings: Tamue Gibson, DFO, Office of Science Coordination and Policy (7201M), Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: (202) 564–7642; email address: gibson.tamue@epa.gov. Risk Evaluations: Dr. Stan Barone, Office of Pollution Prevention and Toxics (7403M), Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: 202–564–1169; email address: barone.stan@epa.gov. Special accommodations for the SACC meeting: For information on access or services for individuals with disabilities, and to request accommodation of a disability, please contact the DFO listed under FOR FURTHER INFORMATION CONTACT at least 10 days prior to the meeting to give EPA as much time as possible to process your request. SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 17:16 Aug 09, 2019 Jkt 247001 I. General Information A. Does this action apply to me? This action is directed to the public in general. This action may be of interest to persons who are or may be required to conduct testing and risk evaluations of chemical substances under the TSCA, 15 U.S.C. 2601 et seq. Since other entities may also be interested in these risk evaluations, the EPA has not attempted to describe all the specific entities that may be affected by this action. B. What action is the EPA taking? EPA is announcing the availability of and seeking public comment on the draft risk evaluation for 1Bromopropane (1–BP). EPA is seeking public comment on all aspects of the draft risk evaluation, including any conclusions, findings, and determinations, and the submission of any additional information that might be relevant to the science underlying the risk evaluation and the outcome of the systematic review associated with the chemical. This 60-day comment period on the draft risk evaluations satisfies TSCA section 6(b)(4)(H), which requires EPA to ‘‘provide no less than 30 days public notice and an opportunity for comment on a draft risk evaluation prior to publishing a final risk evaluation’’ and 40 CFR 702.49(a), which states that ‘‘EPA will publish a draft risk evaluation in the Federal Register, open a docket to facilitate receipt of public comment, and provide no less than a 60day comment period, during which time the public may submit comment on EPA’s draft risk evaluation.’’ In addition to any new comments on the draft risk evaluation, the public should resubmit or clearly identify any previously filed comments, modified as appropriate, that are relevant to the draft risk evaluation and that the submitter feels have not been addressed. EPA does not intend to respond to comments submitted prior to the release of the draft risk evaluation unless they are clearly identified in comments on the draft risk evaluation. EPA is also submitting these same documents to the TSCA SACC for peer review and announcing the meetings for the peer review panel. All comments submitted to the dockets for consideration by the TSCA SACC by the deadline identified in the DATES section will be provided to the TSCA SACC peer review panel, which will have the opportunity to consider the comments during its discussions. PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 39831 C. What is the EPA’s authority for taking this action? TSCA section 6, 15 U.S.C. 2605, requires EPA to conduct risk evaluations to ‘‘determine whether a chemical substance presents an unreasonable risk of injury to health or the environment, without consideration of costs or other nonrisk factors, including an unreasonable risk to a potentially exposed or susceptible subpopulation identified as relevant to the risk evaluation by the Administrator, under the conditions of use.’’ 15 U.S.C. 2605(b)(4)(A). TSCA sections 6(b)(4)(A) through (H) enumerate the deadlines and minimum requirements applicable to this process, including provisions that direct which chemical substances must undergo evaluation, the development of criteria for manufacturer-requested evaluations, the minimum components of an EPA risk evaluation, and the timelines for public comment and completion of the risk evaluation. The law also requires that EPA operate in a manner that is consistent with the best available science and make decisions based on the weight of the scientific evidence. 15 U.S.C. 2625(h) and (i). The statute identifies the minimum components EPA must include in all chemical substance risk evaluations. For each risk evaluation, EPA must publish a document that outlines the scope of the risk evaluation to be conducted, which includes the hazards, exposures, conditions of use, and the potentially exposed or susceptible subpopulations that EPA expects to consider. 15 U.S.C. 2605(b)(4)(D). The statute further provides that each risk evaluation must also: (1) Integrate and assess available information on hazards and exposure for the conditions of use of the chemical substance, including information on specific risks of injury to health or the environment and information on relevant potentially exposed or susceptible subpopulations; (2) describe whether aggregate or sentinel exposures were considered and the basis for that consideration; (3) take into account, where relevant, the likely duration, intensity, frequency, and number of exposures under the conditions of use; and (4) describe the weight of the scientific evidence for the identified hazards and exposure. 15 U.S.C. 2605(b)(4)(F)(i)–(ii) and (iv)–(v). Each risk evaluation must not consider costs or other nonrisk factors. 15 U.S.C. 2605(b)(4)(F)(iii). The statute requires that the risk evaluation process last no longer than three years, with a possible additional six-month extension. 15 U.S.C. E:\FR\FM\12AUN1.SGM 12AUN1 39832 Federal Register / Vol. 84, No. 155 / Monday, August 12, 2019 / Notices 2605(b)(4)(G). The statute also requires that the EPA allow for no less than a 30day public comment period on the draft risk evaluation, prior to publishing a final risk evaluation. 15 U.S.C. 2605(b)(4)(H). jspears on DSK3GMQ082PROD with NOTICES II. TSCA SACC Meetings The focus of the public meeting is to peer review EPA’s draft risk evaluation of 1–BP. After the peer review process, EPA will consider peer reviewer comments and recommendations and public comments, in finalizing the risk evaluation. The draft risk evaluation contains: discussion of chemistry and physical-chemical properties; characterization of conditions of use; environmental fate and transport assessment; human health exposures; environmental hazard assessment; risk characterization; risk determination; and a detailed description of the systematic review process developed by the Office of Pollution Prevention and Toxics to search, screen, and evaluate scientific literature for use in the risk evaluation process. A. How may I participate in the inperson meeting? You may participate in the in person meeting by following the instructions in this unit. To ensure proper receipt by EPA, it is imperative that you identify the corresponding docket ID number for 1–BP (EPA–HQ–OPPT–2019–0235) in the subject line on the first page of your request. 1. Written comments. To provide TSCA SACC the time necessary to consider and review your comments, written comments must be submitted by the date set in the DATES section and using the instructions in the ADDRESSES section and Unit II.C. Comments received after the date set in the DATES section and prior to the end of the oral public comment period during the meeting for each chemical will still be provided to the SACC for their consideration. 2. Oral comments. In order to be included on the meeting agenda, submit your request to make brief oral comments to the TSCA SACC during the in-person meeting to the DFO listed under FOR FURTHER INFORMATION CONTACT on or before the date outlined in the DATES section. The request should identify the name of the individual making the presentation, the organization (if any) the individual will represent, and any requirements for audiovisual equipment. Oral comments before TSCA SACC during the in-person meeting are limited to approximately 5 minutes unless prior arrangements have been made. In addition, each speaker VerDate Sep<11>2014 17:16 Aug 09, 2019 Jkt 247001 should bring 30 copies of his or her comments and presentation for distribution by the DFO to the TSCA SACC at the meeting. 3. Seating at the meeting. Seating at the meeting will be open and on a firstcome basis. B. How may I participate in the preparatory virtual meeting? Registration for the August 21, 2019, preparatory virtual meeting is required. To participate by listening or making a comment during this meeting, please visit:https://www.epa.gov/tsca-peerreview website to register. Registration online will be confirmed by email that will include the webcast meeting link and audio teleconference information. 1. Written comments. Written comments for consideration during the preparatory virtual meeting should be submitted, using the instructions in ADDRESSES and Unit II.C., on or before August 20, 2019. 2. Oral comments. Requests to make brief oral comments to the TSCA SACC during the preparatory virtual meeting should be submitted when registering online or with the DFO listed under FOR FURTHER INFORMATION CONTACT on or before noon on August 20, 2019. Oral comments before TSCA SACC during the preparatory webcast are limited to approximately 5 minutes due to the time constraints of this webcast. 3. Webcast. The preparatory virtual meeting will be webcast only and will be open to the public. Please refer to the TSCA SACC website at https:// www.epa.gov/tsca-peer-review for information on how to access the webcast. Registration is required. C. What should I consider as I prepare my comments for EPA? 1. Submitting CBI. Do not submit CBI to EPA through regulations.gov or email. If your comments contain any information that you consider to be CBI or otherwise protected, please contact the DFO listed under FOR FURTHER INFORMATION CONTACT to obtain special instructions before submitting your comments. 2. Tips for preparing your comments. When preparing and submitting your comments, see the commenting tips at https://www.epa.gov/dockets/ comments.html. III. Background A. What is EPA’s risk evaluation process for existing chemicals under TSCA? The risk evaluation process is the second step in EPA’s existing chemical process under TSCA, following prioritization and before risk PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 management. As this chemical is part of the first ten chemical substances undergoing risk evaluation, the chemical substance was not required to go through prioritization (81 FR 91927, December 19, 2016) (FRL–9956–47). The purpose of risk evaluation is to determine whether a chemical substance presents an unreasonable risk of injury to health or the environment, under the conditions of use, including an unreasonable risk to a relevant potentially exposed or susceptible subpopulation. As part of this process, EPA must evaluate both hazard and exposure, not consider costs or other nonrisk factors, use scientific information and approaches in a manner that is consistent with the requirements in TSCA for the best available science, and ensure decisions are based on the weight-of-scientificevidence. The specific risk evaluation process that EPA has established by rule to implement the statutory process is set out in 40 CFR part 702 and summarized on EPA’s website at https:// www.epa.gov/assessing-and-managingchemicals-under-tsca/risk-evaluationsexisting-chemicals-under-tsca. As explained in the preamble to EPA’s final rule on procedures for risk evaluation (82 FR 33726, July 20, 2017) (FRL– 9964–38), the specific regulatory process set out in 40 CFR part 702, subpart B will be followed for the first ten chemical substances undergoing risk evaluation to the maximum extent practicable. B. What is 1-Bromopropane? 1-Bromopropane (1–BP) is primarily used as a solvent cleaner in vapor and immersion degreasing operations to clean optics, electronics and metals, and it has also been reported to be used as a solvent vehicle in industries using spray adhesives such as those used in foam cushion manufacturing. Information from the 2016 Chemical Data Reporting (CDR) for 1–BP indicates the reported production volume is 25.9 million lbs/year (manufacture and import). Information about the problem formulation and scope phases of the risk evaluation for this chemical is available at https://www.epa.gov/assessing-andmanaging-chemicals-under-tsca/riskevaluation-1-bromopropane-1-bp. C. What is the purpose of the TSCA SACC? The TSCA SACC was established by EPA in 2016 and operates in accordance with the Federal Advisory Committee Act (FACA), 5 U.S.C. Appendix 2 et seq. The SACC supports activities under E:\FR\FM\12AUN1.SGM 12AUN1 Federal Register / Vol. 84, No. 155 / Monday, August 12, 2019 / Notices TSCA, the Pollution Prevention Act (PPA), 42 U.S.C. 13101 et seq., and other applicable statutes. The TSCA SACC provides expert independent scientific advice and recommendations to the EPA on the scientific and technical aspects of risk assessments, methodologies, and pollution prevention measures and approaches for chemicals regulated under TSCA. The TSCA SACC is comprised of experts in: Toxicology; human health and environmental risk assessment; exposure assessment; and related sciences (e.g., synthetic biology, pharmacology, biotechnology, nanotechnology, biochemistry, biostatistics, PBPK modeling, computational toxicology, epidemiology, environmental fate, and environmental engineering and sustainability). The TSCA SACC currently consists of 24 members. When needed, the committee will be assisted in their reviews by ad hoc participants with specific expertise in the topics under consideration. D. TSCA SACC Documents and Meeting Minutes EPA’s background paper, related supporting materials, and draft charge questions to TSCA SACC are available on the TSCA SACC website and in the docket established for the specific chemical. In addition, the EPA will provide additional background documents (e.g., TSCA SACC members participating in this meeting and the meeting agenda) as the materials become available. You may obtain electronic copies of these documents, and certain other related documents that might be available, at https:// www.regulations.gov and the TSCA SACC website at https://www.epa.gov/ tsca-peer-review. TSCA SACC will prepare meeting minutes summarizing its recommendations to the EPA. The meeting minutes will be posted on the TSCA SACC website and in the relevant docket. jspears on DSK3GMQ082PROD with NOTICES Authority: 15 U.S.C. 2601 et seq.; 5 U.S.C. Appendix 2 et seq. Dated: August 5, 2019. Andrew R. Wheeler, Administrator. [FR Doc. 2019–17222 Filed 8–9–19; 8:45 am] BILLING CODE 6560–50–P VerDate Sep<11>2014 17:16 Aug 09, 2019 Jkt 247001 ENVIRONMENTAL PROTECTION AGENCY 39833 SUPPLEMENTARY INFORMATION: I. General Information [EPA–HQ–OPP–2019–0448; FRL–9997–71] A. Does this action apply to me? Nominations to the Federal Insecticide, Fungicide, and Rodenticide Act Scientific Advisory Panel; Request for Comments This action is directed to the public in general. This action may, however, be of interest to persons who are or may be required to conduct testing of chemical substances under the Federal Food, Drug, and Cosmetic Act (FFDCA) and FIFRA. Given other entities may also be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the DFO listed under FOR FURTHER INFORMATION CONTACT. Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: This notice provides the names, addresses, and professional affiliations of persons recently nominated to serve on the Scientific Advisory Panel (SAP) established under section 25(d) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). The Panel was created on November 28, 1975, and made a permanent Panel by amendment to FIFRA, dated October 25, 1988. The Agency, at this time, anticipates selecting three new members to serve on the panel because of membership terms that will expire during the next year. Public comments on the current nominations are invited, as these comments will be used to assist the Agency in selecting the new members for the chartered Scientific Advisory Panel. SUMMARY: Comments identified by docket ID number EPA–HQ–OPP–2019–0448, must be received on or before September 11, 2019. ADDRESSES: Submit your comments, identified by docket identification (ID) number EPA–HQ–OPP–2019–0448, by one of the following methods: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the online instructions for submitting comments. Do not electronically submit any information you consider to be Confidential Business Information (CBI) or information whose disclosure is restricted by statute. • Mail: OPP Docket, Environmental Protection Agency Docket Center (EPA/ DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001. • Hand Delivery: To make special arrangements for hand delivery or delivery of boxed information, please follow the instructions at https:// www.epa.gov/dockets/contacts.html. FOR FURTHER INFORMATION CONTACT: Steven Knott, M.S., Designated Federal Officer (DFO), Office of Science Coordination and Policy (7201M), Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: (202) 564–0103; email address: knott.steven@ epa.gov. DATES: PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 B. What should I consider as I prepare my comments for EPA? 1. Submitting CBI. Do not submit CBI information to EPA through regulations.gov or email. If your comments contain any information that you consider to be CBI or otherwise protected, please contact the DFO listed under FOR FURTHER INFORMATION CONTACT to obtain special instructions before submitting your comments. 2. Tips for preparing your comments. When preparing and submitting your comments, see the commenting tips at https://www.epa.gov/dockets/ comments.html. II. Background The FIFRA SAP serves as a scientific peer review mechanism of EPA’s Office of Chemical Safety and Pollution Prevention (OCSPP) and is structured to provide independent scientific advice, information, and recommendations to the EPA Administrator on pesticides and pesticide-related issues as to the impact of regulatory actions on health and the environment. The FIFRA SAP is a federal advisory committee established in 1975 under FIFRA that operates in accordance with requirements of the Federal Advisory Committee Act (5 U.S.C. Appendix). The FIFRA SAP is composed of a permanent panel consisting of seven members who are appointed by the EPA Administrator from nominees provided by the National Institutes of Health (NIH) and the National Science Foundation (NSF). FIFRA established a Science Review Board (SRB) consisting of at least 60 scientists who are available to the FIFRA SAP on an ad hoc basis to assist in reviews conducted by the FIFRA SAP. As a scientific peer review mechanism, the FIFRA SAP provides comments, evaluations, and recommendations to improve the E:\FR\FM\12AUN1.SGM 12AUN1

Agencies

[Federal Register Volume 84, Number 155 (Monday, August 12, 2019)]
[Notices]
[Pages 39830-39833]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17222]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2019-0235; FRL-9997-25]


1-Bromopropane (1-BP); Draft Toxic Substances Control Act (TSCA) 
Risk Evaluation and TSCA Science Advisory Committee on Chemicals (SACC) 
Meetings; Notice of Availability and Public Meetings

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: EPA is announcing the availability of documents and dates for 
the peer review of the draft risk evaluation for 1-Bromopropane (1-BP). 
The purpose of the risk evaluations under the Toxic Substances Control 
Act (TSCA) is to determine whether a chemical substance presents an 
unreasonable risk of injury to health or the environment under the 
conditions of use, including an unreasonable risk to a relevant 
potentially exposed or susceptible subpopulation. EPA is also 
submitting these same documents to the TSCA Science Advisory Committee 
on Chemicals (SACC) for peer review and is announcing that there will 
be a 3-day in-person meeting of the TSCA SACC to consider and review 
these draft risk evaluations. Preceding the in-person meeting, there 
will be a 3-hour preparatory virtual meeting for the panel to consider 
the scope and clarity of the draft charge questions for the peer 
reviews.

DATES: 
    Comments: Comments on the draft risk evaluation must be received on 
or before October 11, 2019. Please submit comments on the draft risk 
evaluation by August 30, 2019 to allow the SACC time to review and 
consider them before the peer review meeting. Comments received after 
August 30, 2019 will still be provided to the SACC for their 
consideration. For additional instructions, see Unit II.A. and Unit 
II.B. of the SUPPLEMENTARY INFORMATION.
    Meetings: The preparatory virtual meeting will be held on August 
21, 2019, from 1 p.m. to approximately 4 p.m. (EDT). The 3-day in-
person meeting will be held on September 10-12, 2019 from 9:00 a.m. to 
approximately 5:30 p.m. (EDT).

ADDRESSES: Virtual Meeting: The preparatory virtual meeting will be 
conducted via webcast and telephone. Registration is open to the public 
and is required to participate during the preparatory virtual meeting. 
Please visit https://www.epa.gov/tsca-peer-review website for 
additional information including how to register.
    In-Person Meeting: The location of the in-person meeting will be 
announced on the TSCA SACC website at https://www.epa.gov/TSCA-Peer-Review. The in-person meeting may also be webcast. Please refer to the 
TSCA SACC website at https://www.epa.gov/tsca-peer-review for 
information on how to access the webcast. Please note that for the in-
person meeting, the webcast is a supplementary public process provided 
only for convenience. If difficulties arise resulting in webcasting 
outages, the in-person meeting will continue as planned.
    Comments. Submit your comments, identified by docket identification 
(ID) number EPA-HQ-OPPT-2019-0235, by one of the following methods:

[[Page 39831]]

     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the online instructions for submitting comments. Do not submit 
electronically any information you consider to be Confidential Business 
Information (CBI) or other information whose disclosure is restricted 
by statute.
     Mail: OPPT Docket, Environmental Protection Agency Docket 
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC 
20460-0001.
     Hand Delivery: To make special arrangements for hand 
delivery or delivery of boxed information, please follow the 
instructions at https://www.epa.gov/dockets/contacts.html.
    Additional instructions on commenting or visiting the docket, along 
with more information about dockets generally, is available at https://www.epa.gov/dockets.
    Requests to present oral comments and requests for special 
accommodations. Submit requests for special accommodations, or requests 
to present oral comments (in-person or over the telephone) during the 
webcast and/or the public portion of the peer review meeting to the 
Designated Federal Official (DFO) listed under FOR FURTHER INFORMATION 
CONTACT by the deadline identified in the DATES section. Comments 
received after the date set in the DATES section and prior to the end 
of the oral public comment period during the meeting for each chemical 
will still be provided to the SACC for their consideration.

FOR FURTHER INFORMATION CONTACT: TSCA SACC meetings: Tamue Gibson, DFO, 
Office of Science Coordination and Policy (7201M), Environmental 
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-
0001; telephone number: (202) 564-7642; email address: 
[email protected].
    Risk Evaluations: Dr. Stan Barone, Office of Pollution Prevention 
and Toxics (7403M), Environmental Protection Agency, 1200 Pennsylvania 
Ave. NW, Washington, DC 20460-0001; telephone number: 202-564-1169; 
email address: [email protected].
    Special accommodations for the SACC meeting: For information on 
access or services for individuals with disabilities, and to request 
accommodation of a disability, please contact the DFO listed under FOR 
FURTHER INFORMATION CONTACT at least 10 days prior to the meeting to 
give EPA as much time as possible to process your request.

SUPPLEMENTARY INFORMATION: 

I. General Information

A. Does this action apply to me?

    This action is directed to the public in general. This action may 
be of interest to persons who are or may be required to conduct testing 
and risk evaluations of chemical substances under the TSCA, 15 U.S.C. 
2601 et seq. Since other entities may also be interested in these risk 
evaluations, the EPA has not attempted to describe all the specific 
entities that may be affected by this action.

B. What action is the EPA taking?

    EPA is announcing the availability of and seeking public comment on 
the draft risk evaluation for 1-Bromopropane (1-BP). EPA is seeking 
public comment on all aspects of the draft risk evaluation, including 
any conclusions, findings, and determinations, and the submission of 
any additional information that might be relevant to the science 
underlying the risk evaluation and the outcome of the systematic review 
associated with the chemical. This 60-day comment period on the draft 
risk evaluations satisfies TSCA section 6(b)(4)(H), which requires EPA 
to ``provide no less than 30 days public notice and an opportunity for 
comment on a draft risk evaluation prior to publishing a final risk 
evaluation'' and 40 CFR 702.49(a), which states that ``EPA will publish 
a draft risk evaluation in the Federal Register, open a docket to 
facilitate receipt of public comment, and provide no less than a 60-day 
comment period, during which time the public may submit comment on 
EPA's draft risk evaluation.'' In addition to any new comments on the 
draft risk evaluation, the public should resubmit or clearly identify 
any previously filed comments, modified as appropriate, that are 
relevant to the draft risk evaluation and that the submitter feels have 
not been addressed. EPA does not intend to respond to comments 
submitted prior to the release of the draft risk evaluation unless they 
are clearly identified in comments on the draft risk evaluation.
    EPA is also submitting these same documents to the TSCA SACC for 
peer review and announcing the meetings for the peer review panel. All 
comments submitted to the dockets for consideration by the TSCA SACC by 
the deadline identified in the DATES section will be provided to the 
TSCA SACC peer review panel, which will have the opportunity to 
consider the comments during its discussions.

C. What is the EPA's authority for taking this action?

    TSCA section 6, 15 U.S.C. 2605, requires EPA to conduct risk 
evaluations to ``determine whether a chemical substance presents an 
unreasonable risk of injury to health or the environment, without 
consideration of costs or other nonrisk factors, including an 
unreasonable risk to a potentially exposed or susceptible subpopulation 
identified as relevant to the risk evaluation by the Administrator, 
under the conditions of use.'' 15 U.S.C. 2605(b)(4)(A). TSCA sections 
6(b)(4)(A) through (H) enumerate the deadlines and minimum requirements 
applicable to this process, including provisions that direct which 
chemical substances must undergo evaluation, the development of 
criteria for manufacturer-requested evaluations, the minimum components 
of an EPA risk evaluation, and the timelines for public comment and 
completion of the risk evaluation. The law also requires that EPA 
operate in a manner that is consistent with the best available science 
and make decisions based on the weight of the scientific evidence. 15 
U.S.C. 2625(h) and (i).
    The statute identifies the minimum components EPA must include in 
all chemical substance risk evaluations. For each risk evaluation, EPA 
must publish a document that outlines the scope of the risk evaluation 
to be conducted, which includes the hazards, exposures, conditions of 
use, and the potentially exposed or susceptible subpopulations that EPA 
expects to consider. 15 U.S.C. 2605(b)(4)(D). The statute further 
provides that each risk evaluation must also: (1) Integrate and assess 
available information on hazards and exposure for the conditions of use 
of the chemical substance, including information on specific risks of 
injury to health or the environment and information on relevant 
potentially exposed or susceptible subpopulations; (2) describe whether 
aggregate or sentinel exposures were considered and the basis for that 
consideration; (3) take into account, where relevant, the likely 
duration, intensity, frequency, and number of exposures under the 
conditions of use; and (4) describe the weight of the scientific 
evidence for the identified hazards and exposure. 15 U.S.C. 
2605(b)(4)(F)(i)-(ii) and (iv)-(v). Each risk evaluation must not 
consider costs or other nonrisk factors. 15 U.S.C. 2605(b)(4)(F)(iii).
    The statute requires that the risk evaluation process last no 
longer than three years, with a possible additional six-month 
extension. 15 U.S.C.

[[Page 39832]]

2605(b)(4)(G). The statute also requires that the EPA allow for no less 
than a 30-day public comment period on the draft risk evaluation, prior 
to publishing a final risk evaluation. 15 U.S.C. 2605(b)(4)(H).

II. TSCA SACC Meetings

    The focus of the public meeting is to peer review EPA's draft risk 
evaluation of 1-BP. After the peer review process, EPA will consider 
peer reviewer comments and recommendations and public comments, in 
finalizing the risk evaluation. The draft risk evaluation contains: 
discussion of chemistry and physical-chemical properties; 
characterization of conditions of use; environmental fate and transport 
assessment; human health exposures; environmental hazard assessment; 
risk characterization; risk determination; and a detailed description 
of the systematic review process developed by the Office of Pollution 
Prevention and Toxics to search, screen, and evaluate scientific 
literature for use in the risk evaluation process.

A. How may I participate in the in-person meeting?

    You may participate in the in person meeting by following the 
instructions in this unit. To ensure proper receipt by EPA, it is 
imperative that you identify the corresponding docket ID number for 1-
BP (EPA-HQ-OPPT-2019-0235) in the subject line on the first page of 
your request.
    1. Written comments. To provide TSCA SACC the time necessary to 
consider and review your comments, written comments must be submitted 
by the date set in the DATES section and using the instructions in the 
ADDRESSES section and Unit II.C. Comments received after the date set 
in the DATES section and prior to the end of the oral public comment 
period during the meeting for each chemical will still be provided to 
the SACC for their consideration.
    2. Oral comments. In order to be included on the meeting agenda, 
submit your request to make brief oral comments to the TSCA SACC during 
the in-person meeting to the DFO listed under FOR FURTHER INFORMATION 
CONTACT on or before the date outlined in the DATES section. The 
request should identify the name of the individual making the 
presentation, the organization (if any) the individual will represent, 
and any requirements for audiovisual equipment. Oral comments before 
TSCA SACC during the in-person meeting are limited to approximately 5 
minutes unless prior arrangements have been made. In addition, each 
speaker should bring 30 copies of his or her comments and presentation 
for distribution by the DFO to the TSCA SACC at the meeting.
    3. Seating at the meeting. Seating at the meeting will be open and 
on a first-come basis.

B. How may I participate in the preparatory virtual meeting?

    Registration for the August 21, 2019, preparatory virtual meeting 
is required. To participate by listening or making a comment during 
this meeting, please visit:https://www.epa.gov/tsca-peer-review website 
to register. Registration online will be confirmed by email that will 
include the webcast meeting link and audio teleconference information.
    1. Written comments. Written comments for consideration during the 
preparatory virtual meeting should be submitted, using the instructions 
in ADDRESSES and Unit II.C., on or before August 20, 2019.
    2. Oral comments. Requests to make brief oral comments to the TSCA 
SACC during the preparatory virtual meeting should be submitted when 
registering online or with the DFO listed under FOR FURTHER INFORMATION 
CONTACT on or before noon on August 20, 2019. Oral comments before TSCA 
SACC during the preparatory webcast are limited to approximately 5 
minutes due to the time constraints of this webcast.
    3. Webcast. The preparatory virtual meeting will be webcast only 
and will be open to the public. Please refer to the TSCA SACC website 
at https://www.epa.gov/tsca-peer-review for information on how to access 
the webcast. Registration is required.

C. What should I consider as I prepare my comments for EPA?

    1. Submitting CBI. Do not submit CBI to EPA through regulations.gov 
or email. If your comments contain any information that you consider to 
be CBI or otherwise protected, please contact the DFO listed under FOR 
FURTHER INFORMATION CONTACT to obtain special instructions before 
submitting your comments.
    2. Tips for preparing your comments. When preparing and submitting 
your comments, see the commenting tips at https://www.epa.gov/dockets/comments.html.

III. Background

A. What is EPA's risk evaluation process for existing chemicals under 
TSCA?

    The risk evaluation process is the second step in EPA's existing 
chemical process under TSCA, following prioritization and before risk 
management. As this chemical is part of the first ten chemical 
substances undergoing risk evaluation, the chemical substance was not 
required to go through prioritization (81 FR 91927, December 19, 2016) 
(FRL-9956-47). The purpose of risk evaluation is to determine whether a 
chemical substance presents an unreasonable risk of injury to health or 
the environment, under the conditions of use, including an unreasonable 
risk to a relevant potentially exposed or susceptible subpopulation. As 
part of this process, EPA must evaluate both hazard and exposure, not 
consider costs or other nonrisk factors, use scientific information and 
approaches in a manner that is consistent with the requirements in TSCA 
for the best available science, and ensure decisions are based on the 
weight-of-scientific-evidence.
    The specific risk evaluation process that EPA has established by 
rule to implement the statutory process is set out in 40 CFR part 702 
and summarized on EPA's website at https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-evaluations-existing-chemicals-under-tsca. As explained in the preamble to EPA's final rule on 
procedures for risk evaluation (82 FR 33726, July 20, 2017) (FRL-9964-
38), the specific regulatory process set out in 40 CFR part 702, 
subpart B will be followed for the first ten chemical substances 
undergoing risk evaluation to the maximum extent practicable.

B. What is 1-Bromopropane?

    1-Bromopropane (1-BP) is primarily used as a solvent cleaner in 
vapor and immersion degreasing operations to clean optics, electronics 
and metals, and it has also been reported to be used as a solvent 
vehicle in industries using spray adhesives such as those used in foam 
cushion manufacturing. Information from the 2016 Chemical Data 
Reporting (CDR) for 1-BP indicates the reported production volume is 
25.9 million lbs/year (manufacture and import).
    Information about the problem formulation and scope phases of the 
risk evaluation for this chemical is available at https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-evaluation-1-bromopropane-1-bp.

C. What is the purpose of the TSCA SACC?

    The TSCA SACC was established by EPA in 2016 and operates in 
accordance with the Federal Advisory Committee Act (FACA), 5 U.S.C. 
Appendix 2 et seq. The SACC supports activities under

[[Page 39833]]

TSCA, the Pollution Prevention Act (PPA), 42 U.S.C. 13101 et seq., and 
other applicable statutes. The TSCA SACC provides expert independent 
scientific advice and recommendations to the EPA on the scientific and 
technical aspects of risk assessments, methodologies, and pollution 
prevention measures and approaches for chemicals regulated under TSCA.
    The TSCA SACC is comprised of experts in: Toxicology; human health 
and environmental risk assessment; exposure assessment; and related 
sciences (e.g., synthetic biology, pharmacology, biotechnology, 
nanotechnology, biochemistry, biostatistics, PBPK modeling, 
computational toxicology, epidemiology, environmental fate, and 
environmental engineering and sustainability). The TSCA SACC currently 
consists of 24 members. When needed, the committee will be assisted in 
their reviews by ad hoc participants with specific expertise in the 
topics under consideration.

D. TSCA SACC Documents and Meeting Minutes

    EPA's background paper, related supporting materials, and draft 
charge questions to TSCA SACC are available on the TSCA SACC website 
and in the docket established for the specific chemical. In addition, 
the EPA will provide additional background documents (e.g., TSCA SACC 
members participating in this meeting and the meeting agenda) as the 
materials become available. You may obtain electronic copies of these 
documents, and certain other related documents that might be available, 
at https://www.regulations.gov and the TSCA SACC website at https://www.epa.gov/tsca-peer-review.
    TSCA SACC will prepare meeting minutes summarizing its 
recommendations to the EPA. The meeting minutes will be posted on the 
TSCA SACC website and in the relevant docket.

    Authority: 15 U.S.C. 2601 et seq.; 5 U.S.C. Appendix 2 et seq.

    Dated: August 5, 2019.
Andrew R. Wheeler,
Administrator.
[FR Doc. 2019-17222 Filed 8-9-19; 8:45 am]
 BILLING CODE 6560-50-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.